Suchergebnisse - "Hepatocellular* / mortality"

Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer.

Autoren: Altaf, Abdullah Baldo, Andrea Khalil, Mujtaba et al.

Weitere Verfasser: Altaf, Abdullah Baldo, Andrea Khalil, Mujtaba et al.

Schlagwörter: HCC CIR, Aged, Middle Aged, Female, Male, Humans, Bile Duct Neoplasms* / blood, Bile Duct Neoplasms* / mortality, Bile Duct Neoplasms* / surgery, Biomarkers, Tumor / blood, C-Reactive Protein* / analysis, C-Reactive Protein* / metabolism, Carcinoma, Hepatocellular* / blood, Hepatocellular* / mortality, Hepatocellular* / surgery, Cholangiocarcinoma* / blood, Cholangiocarcinoma* / mortality, Cholangiocarcinoma* / surgery, Hepatectomy, Liver Neoplasms* / blood, Liver Neoplasms* / mortality, Liver Neoplasms* / surgery, Lymphocytes, Postoperative Complications / epidemiology, Prognosis, Retrospective Studies

Dateibeschreibung: application/pdf

Verfügbarkeit: http://hdl.handle.net/10400.17/5232

Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics.

Autoren: Akabane, Miho Kawashima, Jun Altaf, Abdullah et al.

Weitere Verfasser: Akabane, Miho Kawashima, Jun Altaf, Abdullah et al.

Schlagwörter: HCC CIR, Aged, Female, Male, Humans, Middle Aged, Biomarkers, Tumor, Carcinoma, Hepatocellular* / blood, Hepatocellular* / mortality, Hepatocellular* / pathology, Hepatocellular* / surgery, Follow-Up Studies, Hepatectomy* / mortality, Liver Neoplasms* / blood, Liver Neoplasms* / mortality, Liver Neoplasms* / pathology, Liver Neoplasms* / surgery, Neoplasm Recurrence, Local* / blood, Local* / metabolism, Local* / mortality, Local* / pathology, Local* / surgery, Retrospective Studies, Prognosis, Survival Rate, Tumor Burden, alpha-Fetoproteins* / metabolism

Dateibeschreibung: application/pdf

Verfügbarkeit: http://hdl.handle.net/10400.17/5157

Impact of Anatomical Resection on Non-transplantable Recurrence Among Patients with Hepatocellular Carcinoma: An International Multicenter Inverse Probability of Treatment Weighting Analysis.

Autoren: Kawashima, Jun Endo, Yutaka Khalil, Mujtaba et al.

Weitere Verfasser: Kawashima, Jun Endo, Yutaka Khalil, Mujtaba et al.

Schlagwörter: Aged, Carcinoma, Hepatocellular* / mortality, Hepatocellular* / pathology, Hepatocellular* / surgery, Follow-Up Studies, Hepatectomy* / methods, Hepatectomy* / mortality, Liver Neoplasms* / pathology, Liver Neoplasms* / surgery, Liver Transplantation, Middle Aged, Humans, Neoplasm Recurrence, Local* / pathology, Local* / surgery, Prognosis, Retrospective Studies, Survival Rate

Dateibeschreibung: application/pdf

Relation: 40323550

Verfügbarkeit: http://hdl.handle.net/10400.17/5145

Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy: A retrospective study

Autoren: Ahmed Allam Mohamed Marie-Luise Berres Philipp Bruners et al.

Quelle: Strahlenther Onkol

Schlagwörter: Male, Aged, 80 and over, Adult, Carcinoma, Hepatocellular, Liver Neoplasms, Radiotherapy Dosage, Carcinoma, Hepatocellular/mortality [MeSH], Liver Neoplasms/surgery [MeSH], Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Progression-Free Survival [MeSH], High-dose radiation therapy, Radiosurgery/methods [MeSH], Original Article, Neoplasm Staging [MeSH], Liver Neoplasms/pathology [MeSH], Carcinoma, Hepatocellular/surgery [MeSH], Male [MeSH], Non-invasive oncologic intervention, Carcinoma, Hepatocellular/radiotherapy [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Carcinoma, Hepatocellular/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Primary liver cancer, Precision Oncology, Prognosis [MeSH], Liver Neoplasms/radiotherapy [MeSH], Radiotherapy Dosage [MeSH], Local ablative therapy, Middle Aged, Radiosurgery, Prognosis, Progression-Free Survival, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Humans, Female, Retrospective Studies, Aged, Neoplasm Staging

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38689147
https://repository.publisso.de/resource/frl:6523574

Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study

Autoren: Sabine Weber Kristian Unger Marianna Alunni-Fabbroni et al.

Quelle: Dig Dis Sci

Schlagwörter: Liver Cirrhosis, Male, Carcinoma, Hepatocellular, Liver Neoplasms, Pilot Projects, Middle Aged, Prognosis, Carcinoma, Hepatocellular/metabolism [MeSH], Female [MeSH], Carcinoma, Hepatocellular/mortality [MeSH], Aged [MeSH], Humans [MeSH], Middle Aged [MeSH], Liver Cirrhosis/metabolism [MeSH], Original Article, Liver Neoplasms/metabolism [MeSH], Male [MeSH], Cancer biology, Biomarkers, Tumor/metabolism [MeSH], Liver cancer, Pilot Projects [MeSH], Prognosis [MeSH], Metabolism, Metabolomics, Metabolomics/methods [MeSH], Biomarkers, Tumor, Humans, Female, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38652389
https://repository.publisso.de/resource/frl:6490658
https://epub.ub.uni-muenchen.de/125816/

Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning

Autoren: Moritz Gross Stefan P. Haider Tal Ze’evi et al.

Quelle: Eur Radiol

Schlagwörter: Male, Gastrointestinal, Carcinoma, Hepatocellular, Liver Neoplasms, Contrast Media, Middle Aged, Prognosis, Magnetic Resonance Imaging, Risk Assessment, Machine Learning, 03 medical and health sciences, 0302 clinical medicine, Female [MeSH], Carcinoma, Hepatocellular/mortality [MeSH], Liver Neoplasms/mortality [MeSH], Machine learning, Aged [MeSH], Liver Neoplasms/diagnostic imaging [MeSH], Humans [MeSH], Risk assessment, Hepatocellular carcinoma, Retrospective Studies [MeSH], Middle Aged [MeSH], Contrast Media [MeSH], Carcinoma, Hepatocellular/diagnostic imaging [MeSH], Male [MeSH], Prognosis [MeSH], Machine Learning [MeSH], Magnetic resonance imaging, Magnetic Resonance Imaging/methods [MeSH], Medical image processing, Risk Assessment/methods [MeSH], Humans, Female, Retrospective Studies, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38536464
https://repository.publisso.de/resource/frl:6495633

The Clinical Relevance of Prior Metabolic and Bariatric Surgery in Alcohol‐Related Liver Disease in a Nationwide Belgian Liver Transplant Population

Autoren: Lefere, Sander Troisi, Roberto Ivan Karam, Vincent et al.

Weitere Verfasser: Lefere, Sander Troisi, Roberto Ivan Karam, Vincent et al.

Quelle: Liver international

Schlagwörter: Male, Adult, obesity, Carcinoma, Hepatocellular, alcohol relapse, Bariatric Surgery, alcohol use disorder, Liver Transplantation/adverse effects, Sciences de la santé humaine, Liver Neoplasms/surgery, Liver Diseases, Alcoholic/surgery, Liver Diseases, Alcoholic/mortality, 03 medical and health sciences, 0302 clinical medicine, RYGB, Belgium, Risk Factors, cancer, Humans, Human health sciences, ELTR, Chirurgie, Belgium/epidemiology, Liver Diseases, Alcoholic, Retrospective Studies, Proportional Hazards Models, Clinical Relevance, Liver Neoplasms/mortality, Liver Neoplasms, Gastroentérologie & hépatologie, Middle Aged, Liver Transplantation, Carcinoma, Hepatocellular/surgery, Bariatric Surgery/adverse effects, Surgery, Female, Human medicine, Carcinoma, Hepatocellular/mortality, Gastroenterology & hepatology, transplantation

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39699872
https://hdl.handle.net/2268/325804
https://doi.org/10.1111/liv.16219
https://hdl.handle.net/10067/2108990151162165141

Albumin-muscle density score predicts overall survival in patients with hepatocellular cancer undergoing treatment with transarterial chemoembolization

Autoren: Surov, Alexey Wienke, Andreas Borggrefe, Jan et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Male, ddc:610, Carcinoma, Hepatocellular, Survival, Research, Liver Neoplasms, Medizin, Middle Aged, Prognosis, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Hepatocellular cancer, Chemoembolization, Therapeutic/adverse effects [MeSH], Female [MeSH], Carcinoma, Hepatocellular/mortality [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Humans [MeSH], Liver Neoplasms/therapy [MeSH], Skeletal musculature, Carcinoma, Hepatocellular/pathology [MeSH], Chemoembolization, Therapeutic/methods [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Carcinoma, Hepatocellular/therapy [MeSH], Survival Rate [MeSH], Liver Neoplasms/pathology [MeSH], Male [MeSH], Muscle, Skeletal/pathology [MeSH], Prognosis [MeSH], Serum Albumin/analysis [MeSH], Transarterial chemoembolization, Transarterial, Humans, Female, Chemoembolization, Therapeutic, Muscle, Skeletal, chemoembolization, Serum Albumin, Retrospective Studies, Aged

Dateibeschreibung: application/pdf; pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39614916
https://pub.uni-bielefeld.de/record/2999988
https://doi.org/10.1007/s00432-024-06043-3
https://nbn-resolving.org/urn:nbn:de:hbz:294-128545
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/docId/12854
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/12854/SurovAlexey30112024.pdf
https://repository.publisso.de/resource/frl:6492571
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85211157887
https://doi.org/10.1007/s00432-024-06043-3
https://www.ncbi.nlm.nih.gov/pubmed/39614916

The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic review

Autoren: Lopez-Lopez V. Kalt F. Zhong J. -H. et al.

Weitere Verfasser: Lopez-Lopez V. Kalt F. Zhong J. -H. et al.

Quelle: Langenbecks Arch Surg
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Schlagwörter: Carcinoma, Hepatocellular, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Methods::Research Design::Patient Selection, Fetge - Càncer - Cirurgia, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms::Carcinoma, Hepatocellular, Fetge - Trasplantació, ENFERMEDADES::neoplasias::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas::carcinoma hepatocelular, BCLC-B, HCC, Liver resection, Liver transplantation, Humans, Hepatectomy, Other subheadings::Other subheadings::Other subheadings::/surgery, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos del sistema digestivo::hepatectomía, Neoplasm Staging, Otros calificadores::Otros calificadores::Otros calificadores::/cirugía, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos del sistema digestivo::intervenciones quirúrgicas::intervenciones quirúrgicas::trasplante de hígado, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos::diseño de la investigación::selección de los pacientes, Patient Selection, Liver Neoplasms, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Digestive System Surgical Procedures::Hepatectomy, Extirpació (Cirurgia), Liver Transplantation, Survival Rate, Systematic Review, Carcinoma, Hepatocellular/mortality [MeSH], Liver Neoplasms/surgery [MeSH], Liver Neoplasms/mortality [MeSH], Hepatectomy [MeSH], Humans [MeSH], Patient Selection [MeSH], Carcinoma, Hepatocellular/pathology [MeSH], Liver Transplantation [MeSH], Neoplasm Staging [MeSH], Survival Rate [MeSH], Liver Neoplasms/pathology [MeSH], Carcinoma, Hepatocellular/surgery [MeSH], ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Digestive System Surgical Procedures::Surgical Procedures, Operative::Surgical Procedures, Operative::Liver Transplantation

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39269544
https://hdl.handle.net/11351/12085
https://hdl.handle.net/11588/974810
https://ddd.uab.cat/record/306723
https://repository.publisso.de/resource/frl:6519063

Impact of IL-8 on Survival after TARE in HCC: A Comprehensive Investigation and External Validation from the SORAMIC Trial

Autoren: Schindler, Aaron Fischer, Janett Beeskow, Anne-Bettina et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Male, Adult, Aged, 80 and over, Carcinoma, Hepatocellular, Biomarkers, Carcinoma, Hepatocellular/mortality [MeSH], Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Liver Neoplasms/therapy [MeSH], Embolization, Therapeutic/methods [MeSH], Translational research, Carcinoma, Hepatocellular/therapy [MeSH], Male [MeSH], Liver cancer, Carcinoma, Hepatocellular/blood [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Interleukin-8/blood [MeSH], Survival Rate [MeSH], Liver Neoplasms/blood [MeSH], Biomarkers, Tumor/blood [MeSH], Research, Prognosis [MeSH], Radiotherapy, Liver Neoplasms, Interleukin-8, Middle Aged, Prognosis, Embolization, Therapeutic, Survival Rate, Biomarkers, Tumor, Humans, Female, Prospective Studies, Aged, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39503874
https://repository.publisso.de/resource/frl:6507888

Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis

Autoren: Schindler, Philipp Kaldewey, Daniel Rennebaum, Florian et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Male, Adult, 0301 basic medicine, 0303 health sciences, Carcinoma, Hepatocellular, Research, Liver Neoplasms, Middle Aged, 03 medical and health sciences, Treatment Outcome, Humans, Female, Chemoembolization, Therapeutic/adverse effects [MeSH], Female [MeSH], Carcinoma, Hepatocellular/mortality [MeSH], TACE, Liver Neoplasms/mortality [MeSH], cTACE, Aged [MeSH], Adult [MeSH], Humans [MeSH], Liver Neoplasms/therapy [MeSH], Treatment Outcome [MeSH], Carcinoma, Hepatocellular/pathology [MeSH], DEB-TACE, Chemoembolization, Therapeutic/methods [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Carcinoma, Hepatocellular/therapy [MeSH], Liver Neoplasms/pathology [MeSH], Male [MeSH], HCC, DSM-TACE, Chemoembolization, Therapeutic, Retrospective Studies, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38710956
https://repository.publisso.de/resource/frl:6496203

Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study

Autoren: Vaghiri, Sascha Lehwald-Tywuschik, Nadja Prassas, Dimitrios et al.

Quelle: Langenbecks Arch Surg

Schlagwörter: Curative resection, Female [MeSH], Carcinoma, Hepatocellular/mortality [MeSH], Liver Neoplasms/surgery [MeSH], Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Hepatocellular carcinoma, Carcinoma, Hepatocellular/pathology [MeSH], 90-day mortality, Retrospective Studies [MeSH], Middle Aged [MeSH], Predictive factors, Risk Factors [MeSH], Liver Neoplasms/pathology [MeSH], Carcinoma, Hepatocellular/surgery [MeSH], Male [MeSH], Research, Young Adult [MeSH], Hepatectomy/mortality [MeSH], Male, Aged, 80 and over, Adult, Carcinoma, Hepatocellular, Liver Neoplasms, Medizin, Middle Aged, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Humans, Hepatectomy, Female, Aged, Retrospective Studies

Dateibeschreibung: Text

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38698255
https://repository.publisso.de/resource/frl:6522062
https://www.ncbi.nlm.nih.gov/pubmed/38698255
https://doi.org/10.1007/s00423-024-03337-5
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85191962497

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Autoren: Richard S. Finn Masatoshi Kudo Ann-Lii Cheng et al.

Weitere Verfasser: Richard S. Finn Masatoshi Kudo Ann-Lii Cheng et al.

Quelle: Clin Cancer Res

Schlagwörter: 0301 basic medicine, Carcinoma, Hepatocellular, Liver Neoplasms / blood, Quinolines / therapeutic use, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Hepatocellular / chemistry, Biomarkers, Tumor, Tumor / analysis, Humans, Liver Neoplasms / mortality, Translational Cancer Mechanisms and Therapy, Hepatocellular / mortality, Liver Neoplasms / drug therapy, Liver Neoplasms / chemistry, Phenylurea Compounds / therapeutic use, Phenylurea Compounds, Carcinoma, Liver Neoplasms, Sorafenib, 3. Good health, Survival Rate, Hepatocellular / blood, Quinolines, Hepatocellular / drug therapy, lenvatinib, hepatocellular carcinoma, Sorafenib / therapeutic use, Tumor / pharmacokinetics, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: http://eprints.gla.ac.uk/239025/1/239025.pdf
https://pubmed.ncbi.nlm.nih.gov/34108184
https://eprints.gla.ac.uk/239025/1/239025.pdf
https://clincancerres.aacrjournals.org/content/early/2021/07/16/1078-0432.CCR-20-4219
https://europepmc.org/article/MED/34108184
https://pubmed.ncbi.nlm.nih.gov/34108184/
https://www.scilit.net/article/91bde2b97da38aa86b91b9f7b71a3b90
https://www.ncbi.nlm.nih.gov/pubmed/34108184
https://clincancerres.aacrjournals.org/content/27/17/4848
https://hdl.handle.net/11585/858933
https://aacrjournals.org/clincancerres/article/27/17/4848/671627/Pharmacodynamic-Biomarkers-Predictive-of-Survival
https://doi.org/10.1158/1078-0432.CCR-20-4219

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

Autoren: Öcal, Osman Schütte, Kerstin Kupčinskas, Juozas et al.

Weitere Verfasser: Öcal, Osman Schütte, Kerstin Kupčinskas, Juozas et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Adult, Male, 0301 basic medicine, Carcinoma, Hepatocellular, Adolescent, Turkey, Hepatocellular carcinoma, Original Article – Clinical Oncology, Carcinoma, Hepatocellular/mortality [MeSH], Disease Progression [MeSH], Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Turkey/epidemiology [MeSH], Aged [MeSH], Sorafenib, Liver Neoplasms/pathology [MeSH], Male [MeSH], Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Response, Liver Neoplasms/diagnosis [MeSH], Adult [MeSH], Humans [MeSH], Carcinoma, Hepatocellular/diagnosis [MeSH], Carcinoma, Hepatocellular/pathology [MeSH], Survival Analysis [MeSH], Predictive Value of Tests [MeSH], Middle Aged [MeSH], Interleukin-8/blood [MeSH], Carcinoma, Hepatocellular/drug therapy [MeSH], Sorafenib/therapeutic use [MeSH], Europe/epidemiology [MeSH], Prognosis [MeSH], Young Adult [MeSH], Interleukin-6/blood [MeSH], Interleukin, Liver Neoplasms/drug therapy [MeSH], Young Adult, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Humans, Aged, Aged, 80 and over, Interleukin-6, Interleukin-8, Liver Neoplasms, Middle Aged, Prognosis, Survival Analysis, 3. Good health, Europe, Disease Progression, Female, Follow-Up Studies

Dateibeschreibung: application/pdf; application/zip; text/xml

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00432-021-03627-1.pdf
https://pubmed.ncbi.nlm.nih.gov/33855585
https://researchinformation.amsterdamumc.org/en/publications/baseline-interleukin-6-and-8-predict-response-and-survival-in-pat
https://pubmed.ncbi.nlm.nih.gov/33855585/
https://link.springer.com/content/pdf/10.1007/s00432-021-03627-1.pdf
https://www.research.manchester.ac.uk/portal/en/publications/baseline-interleukin6-and-8-predict-response-and-survival-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-sorafenib-monotherapy(9acf0a43-982f-45c0-bd0f-93fe602b65cd).html
https://europepmc.org/article/MED/33855585
https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fcb89262e-520c-4d45-8690-93a65ffaa752
https://pure.amsterdamumc.nl/en/publications/4b1fbf50-9abe-4ad5-9035-3fc453c662f2
https://doi.org/10.1007/s00432-021-03627-1
https://hdl.handle.net/10807/204116
https://doi.org/10.1007/s00432-021-03627-1
https://repository.publisso.de/resource/frl:6449874
https://www.repository.cam.ac.uk/handle/1810/333431
https://doi.org/10.17863/cam.80855
https://doi.org/10.1007/s00432-021-03627-1

Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma

Autoren: Hong-Fan Ding Xu-Feng Zhang Fabio Bagante et al.

Quelle: European Journal of Surgical Oncology. 47:660-666

Schlagwörter: Carcinoma, Hepatocellular / surgery, Male, Carcinoma, Hepatocellular, Hepatocellular carcinoma, Liver Neoplasms / pathology, Liver Neoplasms / mortality, 03 medical and health sciences, Liver Neoplasms / surgery, 0302 clinical medicine, Barcelona clinic liver cancer, Carcinoma, Hepatocellular / metabolism, Carcinoma, Hepatocellular / mortality, Humans, Neoplasm Invasiveness, Liver Neoplasms / metabolism, Aged, Neoplasm Staging, Carcinoma, Hepatocellular / pathology, Liver Neoplasms, Neoplasm Recurrence, Local, Middle Aged, HCC CIR, Prognosis, 3. Good health, Survival Rate, Alpha-fetoprotein, Surgery, Female, alpha-Fetoproteins, alpha-Fetoproteins / metabolism

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33082065
https://pubmed.ncbi.nlm.nih.gov/33082065/
https://researchers.mq.edu.au/en/publications/prediction-of-tumor-recurrence-by-%CE%B1-fetoprotein-model-after-curat
https://www.ncbi.nlm.nih.gov/pubmed/33082065
https://www.sciencedirect.com/science/article/pii/S0748798320308490
http://hdl.handle.net/10400.17/4308

Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma

Autoren: Han Ah Lee Seung Up Kim Do Young Kim et al.

Weitere Verfasser: Han Ah Lee Seung Up Kim Do Young Kim et al.

Quelle: Cancer Investigation. 39:274-283

Schlagwörter: radioembolization, Male, Yttrium-90, Carcinoma, Hepatocellular, Liver Neoplasms / therapy, curative treatment, Kaplan-Meier Estimate, Liver Neoplasms / mortality, TARE, Embolization, 03 medical and health sciences, 0302 clinical medicine, Humans, Yttrium Radioisotopes, Hepatocellular / therapy, Retrospective Studies, Therapeutic / methods, Carcinoma, Liver Neoplasms, hepatocellular carcinoma, Chemoradiotherapy, Middle Aged, Embolization, Therapeutic, 3. Good health, Treatment Outcome, Hepatocellular / diagnostic imaging, Hepatocellular / mortality, Female, Liver Neoplasms / diagnostic imaging

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33356630
https://www.ncbi.nlm.nih.gov/pubmed/33356630
https://www.tandfonline.com/doi/full/10.1080/07357907.2020.1870126
https://pubmed.ncbi.nlm.nih.gov/33356630/
https://yonsei.pure.elsevier.com/en/publications/association-between-curative-treatment-after-transarterial-radioe
https://ir.ymlib.yonsei.ac.kr/handle/22282913/182410

Impact of time‐to‐surgery on outcomes of patients undergoing curative‐intent liver resection for BCLC‐0, A and B hepatocellular carcinoma

Autoren: Alfredo Guglielmi Guillaume Martel Aklile Workneh et al.

Quelle: Journal of Surgical Oncology. 123:381-388

Schlagwörter: time-to-surgery, Male, Carcinoma, Hepatocellular, Carcinoma, Hepatocellular / surgery, Databases, Factual, Liver Neoplasms / pathology, liver, Hepatectomy / mortality, Time-to-Treatment, Hepatectomy, Humans, Carcinoma, Hepatocellular / mortality, resection, Liver Neoplasms / mortality, Aged, Neoplasm Staging, Retrospective Studies, Carcinoma, Hepatocellular / pathology, Liver Neoplasms / surgery, Liver Neoplasms, hepatocellular carcinoma, Middle Aged, HCC CHBPT, 3. Good health, BCLC, Survival Rate, Female, Time-to-Treatment / statistics & numerical data, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/33174627
https://www.ncbi.nlm.nih.gov/pubmed/33174627
https://researchers.mq.edu.au/en/publications/impact-of-time-to-surgery-on-outcomes-of-patients-undergoing-cura
https://pubmed.ncbi.nlm.nih.gov/33174627/
https://onlinelibrary.wiley.com/doi/10.1002/jso.26297
http://hdl.handle.net/10400.17/4368

Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres

Autoren: Katharina Carolin Albrecht René Aschenbach Ioannis Diamantis et al.

Quelle: J Cancer Res Clin Oncol

Schlagwörter: Adult, Aged, 80 and over, Male, Antibiotics, Antineoplastic, Carcinoma, Hepatocellular, Liver Neoplasms, Middle Aged, Prognosis, Microspheres, 3. Good health, Survival Rate, 03 medical and health sciences, Carcinoma, Hepatocellular/mortality [MeSH], TACE, Aged, 80 and over [MeSH], Liver Neoplasms/mortality [MeSH], Aged [MeSH], Chemoembolization, Therapeutic/mortality [MeSH], Microspheres [MeSH], Liver Neoplasms/pathology [MeSH], Male [MeSH], Antibiotics, Antineoplastic/therapeutic use [MeSH], Transarterial chemoembolization, Female [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Adult [MeSH], Humans [MeSH], Hepatocellular carcinoma, Carcinoma, Hepatocellular/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Carcinoma, Hepatocellular/drug therapy [MeSH], Doxorubicin-eluting microspheres, Survival Rate [MeSH], Prognosis [MeSH], Doxorubicin/therapeutic use [MeSH], Liver Neoplasms/drug therapy [MeSH], 0302 clinical medicine, Doxorubicin, Humans, Female, Chemoembolization, Therapeutic, 10. No inequality, Aged, Follow-Up Studies, Retrospective Studies

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00432-020-03370-z.pdf
https://pubmed.ncbi.nlm.nih.gov/32880029
https://link.springer.com/content/pdf/10.1007/s00432-020-03370-z.pdf
https://link.springer.com/article/10.1007/s00432-020-03370-z
https://pubmed.ncbi.nlm.nih.gov/32880029/
https://www.ncbi.nlm.nih.gov/pubmed/32880029
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810642
https://repository.publisso.de/resource/frl:6469394

Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea

Autoren: Yeon Seok Seo Young Chang Young-Sun Lee et al.

Weitere Verfasser: Yeon Seok Seo Young Chang Young-Sun Lee et al.

Quelle: Investigational New Drugs. 39:260-268

Schlagwörter: Male, 0301 basic medicine, Hepatocellular carcinoma, Pyridines, Effectiveness, Kaplan-Meier Estimate, Liver Neoplasms / mortality, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Pyridines / therapeutic use, Sorafenib / adverse effects, Aged, 80 and over, Liver Neoplasms / drug therapy, Antineoplastic Agents / administration & dosage, Phenylurea Compounds / therapeutic use, Liver Neoplasms, Age Factors, Real-world study, Middle Aged, Phenylurea Compounds / adverse effects, Progression-Free Survival, 3. Good health, Hepatocellular / drug therapy, Phenylurea Compounds / administration & dosage, Female, Safety, Adult, Carcinoma, Hepatocellular, Liver Neoplasms / pathology, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, Pyridines / adverse effects, 03 medical and health sciences, Sex Factors, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Republic of Korea, Humans, Aged, Retrospective Studies, Phenylurea Compounds, Antineoplastic Agents / adverse effects, Carcinoma, Patient Acuity, Sorafenib / administration & dosage, Hepatocellular / mortality, Hepatocellular / pathology, Sorafenib / therapeutic use, Pyridines / administration & dosage

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/32749658
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/33931
https://www.ncbi.nlm.nih.gov/pubmed/32749658
https://pubmed.ncbi.nlm.nih.gov/32749658/
https://link.springer.com/article/10.1007/s10637-020-00977-4
https://koreauniv.pure.elsevier.com/en/publications/real-world-systemic-sequential-therapy-with-sorafenib-and-regoraf

Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea–Japan Multicenter Study

Autoren: Jong Man Kim Dong-Sik Kim Bong-Wan Kim et al.

Weitere Verfasser: Jong Man Kim Dong-Sik Kim Bong-Wan Kim et al.

Quelle: Annals of Surgery. 271:913-921

Schlagwörter: Thrombosis / pathology, Male, Carcinoma, Hepatocellular, Liver Neoplasms / mortality, survival, jaundice, Thrombosis / mortality, 03 medical and health sciences, Liver Neoplasms / surgery, 0302 clinical medicine, Japan, Bile Duct Neoplasms / mortality, Recurrence, Risk Factors, Republic of Korea, Humans, Retrospective Studies, Carcinoma, Liver Neoplasms, Thrombosis, Middle Aged, Prognosis, 3. Good health, Survival Rate, Bile Duct Neoplasms / pathology, bile duct resection, Bile Duct Neoplasms, thrombectomy, liver resection, Hepatocellular / mortality, Female, Hepatocellular / surgery

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/30216223
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/49348
https://pubmed.ncbi.nlm.nih.gov/30216223/
https://www.ncbi.nlm.nih.gov/pubmed/30216223
https://journals.lww.com/10.1097/SLA.0000000000003014
https://koreauniv.pure.elsevier.com/en/publications/surgical-outcomes-of-hepatocellular-carcinoma-with-bile-duct-tumo